Average Co-Inventor Count = 2.74
ph-index = 30
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pneuma Respiratory, Inc. (18 from 19 patents)
2. Eyenovia, Inc. (12 from 22 patents)
3. Ochoa Optics LLC (11 from 11 patents)
4. Other (8 from 832,966 patents)
5. Cree Gmbh (7 from 2,307 patents)
6. Google Inc. (6 from 32,622 patents)
7. World Theatre, Inc. (5 from 5 patents)
8. C3 Corporation (4 from 12 patents)
9. Corinthian Ophthalmic, Inc. (3 from 3 patents)
10. Zarbana Digital Fund LLC (2 from 38 patents)
11. Novus Partners, LLC (2 from 7 patents)
12. Next Safety, Inc. (2 from 4 patents)
13. North Carolina State University (1 from 1,442 patents)
83 patents:
1. 12521498 - Droplet delivery device with location control
2. 12491324 - Droplet device with inertial filtering
3. 12403269 - Droplet delivery device with push ejection
4. 12285559 - Nasal drug delivery apparatus and methods of use
5. 12268517 - Drop generating device
6. 12029682 - Spray ejector mechanisms and devices providing charge isolation and controllable droplet charge, and low dosage volume ophthalmic administration
7. 12023700 - Spray ejector device and methods of use
8. 11793945 - Droplet delivery device with push ejection
9. 11771852 - Electronic breath actuated in-line droplet delivery device with small volume ampoule and methods of use
10. 11738158 - Electronic breath actuated in-line droplet delivery device and methods of use
11. 11529476 - Dry powder delivery device and methods of use
12. 11458267 - Nasal drug delivery apparatus and methods of use
13. 11285283 - Methods for generating and delivering droplets to the pulmonary system using a droplet delivery device
14. 11285274 - Methods for the systemic delivery of therapeutic agents to the pulmonary system using a droplet delivery device
15. 11285284 - Methods for treatment of pulmonary lung diseases with improved therapeutic efficacy and improved dose efficiency